206TiP Randomized, multicenter, international phase III ARTEST study to evaluate enobosarm versus active control for the treatment of AR+ ER+ HER2- metastatic breast cancer in patients who previously received an estrogen-blocking agent and a CDK 4/6 inhibitor
| Autor: | Brufsky, A., Linden, H., Rugo, H.S., Vogel, C., O'Shaughnessy, J., Getzenberg, R.H., Barnette, K.G., Rodriguez, D., Steiner, M.S., Mayer, E. |
|---|---|
| Zdroj: | In Annals of Oncology May 2022 33 Supplement 3:S221-S221 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|